ASBP (Aspire-Lakewood Holdings) Issuance of Debt: $9.25 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASBP Aspire-Lakewood Holdings Inc ASBP
11 GF Score
Price $9.25
! 2 Warning Signs
View Full Analysis

What is Aspire-Lakewood Holdings Issuance of Debt?

Aspire-Lakewood Holdings ASBP +2.42% 11 Issuance of Debt is $9.25 Mil as of Jun. 2026. GuruFocus rates ASBP with a GF Score™ of 11/100. The stock has 2 warning signs investors should review.

Aspire-Lakewood Holdings's Issuance of Debt for the three months ended in Jun. 2026 was $0.00 Mil.

Aspire-Lakewood Holdings's Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2026 was $9.25 Mil.

Aspire-Lakewood Holdings Issuance of Debt Related Terms

Aspire-Lakewood Holdings Issuance of Debt Historical Data

* Premium members only.

The historical data trend for Aspire-Lakewood Holdings's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aspire-Lakewood Holdings Issuance of Debt Chart

Aspire-Lakewood Holdings Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Issuance of Debt
0.00 0.00 0.00 10.30

Aspire-Lakewood Holdings Quarterly Data
Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 7.25 0.00 2.00 0.00
ASBP
11GF Score
Aspire-Lakewood Holdings Inc ASBP
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aspire-Lakewood Holdings Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of $9.25 Mil mean?
Aspire-Lakewood Holdings (ASBP) has a Issuance of Debt of $9.25 Mil as of Jun. 2026. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Aspire-Lakewood Holdings and its competitors.
Is Aspire-Lakewood Holdings' Issuance of Debt too high?
Aspire-Lakewood Holdings' current Issuance of Debt is $9.25 Mil. Overall, Aspire-Lakewood Holdings has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Aspire-Lakewood Holdings' Issuance of Debt compare to PDSB and KPRX?
Aspire-Lakewood Holdings' Issuance of Debt of $9.25 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Biotechnology company?
A good Issuance of Debt depends on the Biotechnology industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Aspire-Lakewood Holdings and its competitors. Aspire-Lakewood Holdings's current Issuance of Debt is $9.25 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspire-Lakewood Holdings stock overvalued right now?
Aspire-Lakewood Holdings (ASBP) has a current Issuance of Debt of $9.25 Mil. The current Issuance of Debt is $9.25 Mil. Aspire-Lakewood Holdings' overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For Aspire-Lakewood Holdings (ASBP), the current Issuance of Debt is $9.25 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aspire-Lakewood Holdings Business Description

Address 23150 Fashion Drive, Suite 232, Estero, FL, USA, 33928
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.
11GF Score

Get the complete analysis for ASBP

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.25
Price